Dr. Julie Nonnekens, Erasmus MC

Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer

CT, PET, SPECT

This webinar describes the key applications of nuclear imaging in immuno-oncology. Currently, numerous immuno-oncological drugs are being developed to treat cancer patients. However, many questions remain unanswered, such as how, when, and for whom this treatment is most effective. Dr. Sandra Heskamp will show a few examples of imaging approaches developed in her group to tackle these questions.

November, 2020

Related webinars

Synergetic Photon Tomography from 1eV to 1MeV: Integrated Ultra-high Definition PET, SPECT, X-ray and Optical CT
Synergetic Photon Tomography from 1eV to 1MeV: Integrated Ultra-high Definition PET, SPECT, X-ray and Optical CT
In vivo molecular imaging for the preclinical development and validation of radiopharmaceuticals
In vivo molecular imaging for the preclinical development and validation of radiopharmaceuticals
No results found.
Share this webinar

Want to know what MILabs can do for you?